Dinesh V. Ph.D. Patel, President and CEO of Protagonist Therapeutics, Inc. (PTGX), executed a significant sale of company shares on May 12, 2026. Patel divested 75,000 shares at an average price of $100.12 per share, resulting in a transaction valued at approximately $7.51 million.
This transaction adds to recent insider selling activity within Protagonist Therapeutics. Earlier in May, Bryan Giraudo also reported multiple share sales.
Insider sales can be influenced by a variety of factors, including personal financial planning, diversification strategies, or adherence to pre-established trading plans. Such transactions do not necessarily indicate a shift in the insider's fundamental view of the company's prospects.